US$ 26.02
foxo4-dri senolytic peptide human trials trial Development of a novel senolytic by precise disruption of FOXO4- FOXO4-DRI induces keloid senescent fibroblast
Description
99% purity verified with batch-level COAs available

Supports mitochondrial health and energy production

For instance, a study published in the journalAntioxidantsfound that individuals who took oral glutathione supplements showed increased levels of the antioxidant in their bloodstream, suggesting that oral supplementation is effective
Premium research peptide for cellular health and longevity studies

Regenerative Support for Youthful Aging, Skin, and Cognitive Health

A convenient, fast-absorbing option for personalized care.
